BioStem Technologies, Inc.
BSEM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $227 | $80 | $34 | $12 |
| - Cash | $23 | $0 | $1 | $0 |
| + Debt | $5 | $5 | $5 | $5 |
| Enterprise Value | $208 | $85 | $39 | $17 |
| Revenue | $302 | $17 | $7 | $4 |
| % Growth | 1,708.9% | 142.7% | 58.4% | – |
| Gross Profit | $288 | $15 | $6 | $3 |
| % Margin | 95.4% | 92.4% | 87.2% | 66% |
| EBITDA | $31 | -$8 | -$7 | -$1 |
| % Margin | 10.4% | -45.3% | -94.8% | -13.9% |
| Net Income | $32 | -$8 | -$7 | -$1 |
| % Margin | 10.6% | -50.8% | -102.9% | -33.3% |
| EPS Diluted | 1.47 | -0.62 | -0.62 | -0.12 |
| % Growth | 337.1% | 0% | -416.7% | – |
| Operating Cash Flow | $24 | -$3 | -$2 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $24 | -$4 | -$2 | -$0 |